File picture: IANS
File picture: IANS

Testing underway to determine effectiveness of arthritis drug as coronavirus treatment

By Reuters Time of article published Mar 16, 2020

Share this article:

Sanofi SA and partner Regeneron Pharmaceuticals Inc have started a clinical trial of their rheumatoid arthritis drug Kevzara as a treatment for the coronavirus, the companies said on Monday.

Enrolments for the mid-to-late stage trial will begin immediately, and the companies anticipate the trial will test up to 400 patients.

Kevzara is an infection-fighting protein known as monoclonal antibody.

Regeneron in February announced a partnership with the US Department of Health and Human Services to develop a coronavirus treatment, and had said it would focus on monoclonal antibodies.

* For the latest on the Covid-19 outbreak visit IOL's #Coronavirus trend page.

** If you think you have been exposed to the Covid-19 virus, please call the 24-hour hotline on 0800 029 999 

*** Receive IOL's top stories via Whatsapp by sending your name to 0745573535 

**** Follow IOL on Facebook and Twitter to join the conversation and stay updated with the latest news.


Share this article:

Related Articles